Eli Lilly’s monoclonal antibody treatment reduces risk of severe COVID-19, drugmaker reports – USA TODAY

by



[ad_1]

  1. Eli Lilly’s monoclonal antibody treatment reduces risk of severe COVID-19, drugmaker reportsUSA TODAY
  2. Lilly antibody drug prevents Covid-19 in nursing homes, study findsThe Wall Street Journal
  3. Antibody drug Eli Lilly reduces risk of Covid in nursing homes: studyCNBC Television
  4. Lilly’s neutralizing antibody, bamlanivimab (LY-CoV555), prevented COVID-19 in nursing homes in BLAZE-2 trial, reducing risk to residents by up to 80%PRNewswire
  5. Eli Lilly says his monoclonal antibody prevented Covid-19 in clinical trialSTAT
  6. View full coverage on Google News

[ad_2]

Source link